Skip to main content

Advertisement

SpringerLink
Log in

Comparison of Self-Efficacy for Managing Chronic Disease between patients with systemic sclerosis and other chronic conditions: a systematic review

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The complexity and burden of systemic sclerosis (SSc) pose challenges to developing and sustaining disease management self-efficacy. The objective of this systematic review was to compare scores on a commonly used self-efficacy measure, the Self-Efficacy for Managing Chronic Disease (SEMCD) Scale, between SSc and other diseases. Data sources included the CINAHL, EMBASE, MEDLINE, and Scopus databases, searched through January 25, 2016, and reference lists of included articles and relevant reviews. Studies in any language that reported total SEMCD scores or individual item scores in adult non-psychiatric medical patients were eligible. We identified one eligible non-intervention study of SSc patients (n = 553), 13 other non-intervention studies, and 21 studies with pre-intervention data for patients enrolled in a self-management program or a trial of a program. Of 13 non-intervention studies with published total score means in cancer, cardiovascular disease, Parkinson’s disease, spinal cord injuries, organ transplant candidates and recipients, dialysis, and lupus, SEMCD scores were statistically significantly lower (poorer self-efficacy) in SSc than 6 other disease samples, not significantly different from 6, and significantly higher than lupus patients. Compared to 18 studies of patients in self-management programs or trials with published total score means, SSc patients were similar or lower than 9 samples and significantly higher than 9 samples. Compared to patients with other diseases not enrolled in programs to improve self-efficacy, SSc patients report lower self-efficacy scores than most patient groups. Rigorously tested self-care interventions designed to meet the unique needs of patients with SSc are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Seibold J (2005) Scleroderma. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S et al (eds) Kelley’s textbook of rheumatology, 7th edn. Elsevier, Philadelphia (PA), pp 1279–1308

    Google Scholar 

  2. Wigley FM, Hummers LK (2003) Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS et al (eds) Rheumatology, 3rd edn. Mosby, Philadelphia, pp 1463–1480

    Google Scholar 

  3. Thombs BD, van Lankveld W, Bassel M et al (2010) Psychological health and well-being in systemic sclerosis: state of the science and consensus research agenda. Arthritis Care Res 62:1181–1189

    Article  Google Scholar 

  4. Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD (2011) Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology 50:762–767

    Article  PubMed  Google Scholar 

  5. Kwakkenbos L, Jewett LR, Baron M, Bartlett SJ, Furst D, Gottesman K et al (2013) The Scleroderma Patient-centered Intervention Network (SPIN): protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context. BMJ Open 3:eoo3563

    Article  Google Scholar 

  6. Kwakkenbos L, Delisle VC, Fox RS, Gholizadeh S, Jewett LR, Levis B et al (2015) Psychosocial aspects of scleroderma. Rheum Dis Clin N Am. 41:519–528

    Article  Google Scholar 

  7. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L et al (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 68:620–628

    Article  CAS  PubMed  Google Scholar 

  8. Newman S, Steed L, Mulligan K (2004) Self-management interventions for chronic illness. Lancet 364:1523–1537

    Article  PubMed  Google Scholar 

  9. European Organisation for Rare Diseases (2005) Rare diseases: understanding this public health priority. http://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf. Accessed 31 Jan 2016

  10. Delisle VC, Gumuchian ST, Peláez S, Malcarne VL, El-Baalbaki G, Körner A, et al. Reasons for non-participation in scleroderma support groups. Clin Exp Rheumatol. In press

  11. Bandura A (1977) Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84:191–215

    Article  CAS  PubMed  Google Scholar 

  12. Lorig KR, Ritter PL, Laurent DD, Plant K (2006) Internet-based chronic disease self-management: a randomized trial. Med Care 44:964–971

    Article  PubMed  Google Scholar 

  13. Ritter PL, Lorig K (2014) The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol 67:1265–1273

    Article  PubMed  Google Scholar 

  14. Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

his study was supported by funding to the Scleroderma Patient-centered Intervention Network from the Canadian Institutes of Health Research (PI Thombs; TR3-119192). Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. Dr. Kwakkenbos was supported by a CIHR Banting Postdoctoral Fellowship.

Author information

Authors and Affiliations

  1. Lady Davis Institute for Medical Research, Jewish General Hospital, 4333 Cote Ste Catherine Road, Montreal, QC, H3T 1E4, Canada

    Brett D. Thombs, Linda Kwakkenbos, Kira E. Riehm, Nazanin Saadat & Claire Fedoruk

  2. Department of Psychiatry, McGill University, Montreal, QC, Canada

    Brett D. Thombs & Linda Kwakkenbos

  3. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada

    Brett D. Thombs

  4. Department of Medicine, McGill University, Montreal, QC, Canada

    Brett D. Thombs

  5. Department of Psychology, McGill University, Montreal, QC, Canada

    Brett D. Thombs

  6. Department of Educational and Counselling Psychology, McGill University, Montreal, QC, Canada

    Brett D. Thombs

  7. Behavioural Science Institute, Clinical Psychology, Radboud University, Nijmegen, The Netherlands

    Linda Kwakkenbos

Authors
  1. Brett D. Thombs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Kwakkenbos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kira E. Riehm
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nazanin Saadat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claire Fedoruk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brett D. Thombs.

Ethics declarations

Conflict of interest

Authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thombs, B.D., Kwakkenbos, L., Riehm, K.E. et al. Comparison of Self-Efficacy for Managing Chronic Disease between patients with systemic sclerosis and other chronic conditions: a systematic review. Rheumatol Int 37, 281–292 (2017). https://doi.org/10.1007/s00296-016-3602-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-016-3602-4

Keywords

Search

Navigation